Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case report
نویسندگان
چکیده
منابع مشابه
Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case report
BACKGROUND To describe the first reported case of toxic optic neuropathy secondary to docetaxel (Taxotere®) chemotherapy. CASE PRESENTATION A 53-year-old female presented with predominantly unilateral visual loss, but extensive bilateral visual field defects and bilateral optic nerve head swelling 2 weeks after first dose of docetaxel (Taxotere®) and trastuzumab (Herceptin®) chemotherapy for ...
متن کاملPresumed Chemotherapy-Induced Optic Neuropathy and Maculopathy: A Case Report
Purpose With the advent of more aggressive cytotoxic chemotherapy regimens, the incidence of ocular toxicity due to these drugs is also on the rise. We report a case of Presumed Chemotherapy-Induced optic neuropathy and maculopathy secondary to treatment with cytarabine and daunorubicin for Acute Myeloid Leukaemia (AML). Case report A 50-year-old man with AML developed sudden decrease in visi...
متن کاملLinezolid-associated toxic optic neuropathy: a report of 2 cases.
We describe 2 cases in which the prolonged use of linezolid to treat complicated methicillin-resistant Staphylococcus aureus infections was followed by acutely developed blurred vision and progressive loss of vision and color perception during the ensuing few weeks. Both patients received a diagnosis of toxic optic neuropathy, and linezolid therapy was stopped. The patients experienced an initi...
متن کاملToxic / Nutritional Optic Neuropathy
DOS Times Vol. 11, No. 8 February, 2006 These disorders are often grouped together as they cause a syndrome characterized by papillomacular bundle damage, central or cecocentral scotoma, and reduction of color vision. The anterior visual pathway is susceptible to damage from toxins or nutritional deficiency (Table 1). Both toxicity and malnutrition, acting either independently or together, have...
متن کاملToxic optic neuropathy
Toxic optic neuropathy (TON) is a disease entity which is not only underdiagnosed, but also often diagnosed at a stage when recovery of vision is not possible. This article gives an overview of common causes, clinical features, and management of TON.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Ophthalmology
سال: 2014
ISSN: 1471-2415
DOI: 10.1186/1471-2415-14-18